Nebivolol Sandoz (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Sandoz, is a beta‑blocker presented as a tablet for oral use. It treats hypertension and may be used in patients with heart failure to improve cardiac function and reduce blood‑pressure‑related risks.

GNH USA supplies Nebivolol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in cardiovascular disease management.

Hypertension: lowers systolic and diastolic blood pressure in adults with essential hypertension. Heart failure: improves left‑ventricular function and reduces hospitalization in chronic heart‑failure patients (where approved). Left ventricular dysfunction: supports cardiac output in patients with reduced ventricular performance.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Dizziness: sensation of light‑headedness, especially on standing. - Bradycardia: slower than normal heart rate. - Nausea: upset stomach or urge to vomit. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Hypotension: dangerously low blood pressure. - Bronchospasm: narrowing of airways, especially in asthmatic patients. - Heart block: impaired electrical conduction in the heart. - Allergic reactions: rash, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating Nebivolol, clinicians should evaluate patient‑specific factors and monitor for potential risks.

Monitor blood pressure: ensure adequate control without excessive hypotension. Assess cardiac function: evaluate heart rate and rhythm regularly. Use caution in asthma/COPD: β‑blockade may exacerbate bronchospasm. Review concomitant beta‑blockers: avoid additive cardiac depression. Adjust in renal impairment: dose may need modification in severe kidney disease. Store at ambient temperature: keep in the original pack, protect from moisture.

Nebivolol can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other beta‑blockers: additive negative chronotropic effects. - Non‑dihydropyridine calcium‑channel blockers (verapamil, diltiazem): may cause severe bradycardia or AV block. - Potent CYP2D6 inhibitors (paroxetine, fluoxetine): increase nebivolol plasma levels. - Clonidine abrupt withdrawal: risk of rebound hypertension. - Alpha‑blockers (prazosin): may lead to orthostatic hypotension.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - ACE inhibitors/ARBs: combined blood‑pressure lowering. - NSAIDs: may reduce antihypertensive efficacy. - Antidiabetic agents: possible alteration of glucose control. - Other antihypertensives: monitor for additive hypotension.